← Back to leaderboard
NYR

Matt Rempe

New York Rangers C Age 24 RFA

2025-26· Data as of July 27, 2026

$975K AAV
2 Years Left
RFA Expiry

Status derived from CBA rules; edge cases (Group 6 UFA, 10.2(c), 35+ contracts) may be misclassified. Years remaining are not yet tracked.

17 Value Score
17th percentile among forwards
Verdict Low sample

Not enough games yet to value this contract

Career ledger 2023-24 onward · 2 seasons in window

+0.02 cap-years of surplus ≈ +$1.6M

Judged as-of — each season priced with only the model and data available then — Matt Rempe has delivered 0.02 cap-years more value than he's been paid across our data window. One cap-year = a full season's salary-cap ceiling.

Career still active — this total will keep moving.

Low-confidence total — thin or short seasons drive a large share of the swing, so read it with caution.

Comparable deals See all comparable deals →
Why this verdict

Why this verdict

Where this contract sits vs. the market

Each dot is a real free-agent signing (2015-2026): 1082 comparable forward deals. The line is the going rate at each talent level, the market convention we price against. Real signings scatter around it; comparable players don’t all sign for the identical number.

Pay, % of cap
← lower talent higher talent →
Cap hit $975K Market rate $1.1M +$110K vs. the open market

The page’s headline verdict, −$135K/yr, refines this by adjusting the market rate for age, contract term, and restricted-free-agent status. The plot compares to the raw market curve; the verdict adjusts it.

This player is on an RFA (restricted) contract. Part of the gap below the curve is CBA cost control (teams pay restricted players below open-market value by rule), not evidence of a market inefficiency.

Structurally similar active deals

This contract sits in the Young / bridge region of the contract map. These are the active contracts whose shape is nearest to it, closest in spend, term, age, and role (not how they aged):

Comparable by the shape of the deal, not by team or playing style. Archetypes are broad regions on a continuum; a deal near a boundary is genuinely in-between.

Career Trajectory
VALUE SCORE050100PAY DELTA+$135K−$135K2023-242024-252025-26
Outlook

Outlook

Aging Curve

Approaching his peak

Production index for forwards. The dot marks Matt at age 24.

Empirical production-by-age index (delta-method WAR fit, 2010-11+). Illustrative of typical aging; the dollar model prices age with a separate, softer decline.

0.250.500.751.0182226303437

No as-of track record for this deal yet — a leakage-free record needs at least two seasons graded as-of (coverage runs through 2024-25). The current-season verdict is above.

Full stats

Full stats

Career xG IMPACT/60

Limited career 5v5 sample — a teammate-adjusted (RAPM) impact needs more ice time than this player has logged, so we don't show a point estimate yet. It appears once career 5v5 ice time clears the reliability floor.

Production

Counted outcomes — totals and rates that carry shooting and goaltending luck.

SeasonGPGAPTOI
2025-26261018.6
2024-25423588.5
2023-24171125.6
On-ice & expected

On-ice shot shares and modeled expected goals — these stabilize faster than goal totals, but xG is an estimate, not a count.

SeasonCF%xGxGF
2025-2650.92.38.2
2024-2543.23.211.6
2023-2450.01.43.0
CF%
Corsi-for percentage — share of shot attempts while on the ice
xG
Individual expected goals from the player's own shot attempts
xGF
On-ice expected goals — team's xG while this player is on the ice
Playoff track record

Playoff track record

11 playoff games · 1 postseason

Not enough playoff games to assess.

Descriptive only — not part of Value Score or Fair Value. Playoff samples are small and team-dependent; shown for the record.